ThrombolyticDrugsagentsthatdissolveblood clots3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerProtamineSulfateAntidoteforheparinHomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.alteplaseprototypethrombolyticdrugThrombolysisDissolutionof bloodclotsVitaminKantidoteforwarfarindabigatranThe onlyoral directthrombininhibitorDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.tranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.Heparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationRivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XaIdarucizumabAntidotefordabigatranClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.AminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotHemorrhagemajor sideeffect ofHeparintherapywarfarinPrototypevitamin KantagonistActionofwarfarinActs in theliver topreventsynthesis ofvitamin KPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarinDVTand PEHeparin isgivenprophylacticallyto patients toprevent theseHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiesaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeThrombolyticDrugsagentsthatdissolveblood clots3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerProtamineSulfateAntidoteforheparinHomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.alteplaseprototypethrombolyticdrugThrombolysisDissolutionof bloodclotsVitaminKantidoteforwarfarindabigatranThe onlyoral directthrombininhibitorDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.tranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.Heparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationRivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XaIdarucizumabAntidotefordabigatranClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.AminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotHemorrhagemajor sideeffect ofHeparintherapywarfarinPrototypevitamin KantagonistActionofwarfarinActs in theliver topreventsynthesis ofvitamin KPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarinDVTand PEHeparin isgivenprophylacticallyto patients toprevent theseHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiesaPTTlaboratory testused to see ifheparin iswithintherapeuticrange

Chapter 9 Drug Therapy for Coagulation Disorders - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. agents that dissolve blood clots
    Thrombolytic Drugs
  2. QSEN Alert: The nurse should hold the dose of warfarin if the INR is above this number and notify the health care provider
    3
  3. Antidote for heparin
    Protamine Sulfate
  4. Process that maintains the integrity of the vascular compartment.
    Homeostasis
  5. prototype thrombolytic drug
    alteplase
  6. Dissolution of blood clots
    Thrombolysis
  7. antidote for warfarin
    Vitamin K
  8. The only oral direct thrombin inhibitor
    dabigatran
  9. Heparin is used to treat this life-threatening condition characterized by widespread clotting, which depletes the blood of coagulation factors.
    Disseminated intravascular coagulation (DIC)
  10. Reversal of thrombolytic agent used for short periods in patients with hemophilia to prevent or decrease breeding form tooth extraction or menorrhagia.
    tranexamic acid
  11. inhibits the conversion of prothrombin to thrombin and prevents thrombus formation
    Heparin
  12. direct factor Xa inhibitor prototype that inhibits platelet activation and formation of fibrin clotting by inhibition of factor Xa
    Rivaroxaban
  13. Antidote for dabigatran
    Idarucizumab
  14. prototype Adenosine diphosphate receptor antagonist that irreversibly blocks the ADP receptor on platelet cell surface.
    Clopidogrel
  15. Reversal of thrombolytic agent used in cardiac surgery, blood disorders, hepatic cirrhosis, prostatectomy, and neoplastic disorders
    Aminocaproic acid
  16. Reversal of warfarin overdose with acute major bleeding or in need of emergent surgery
    PCC
  17. An inactive protein present in many body tissues and fluids that is bound to fibrin and becomes a component of a blood clot
    Plasminogen
  18. major side effect of Heparin therapy
    Hemorrhage
  19. Prototype vitamin K antagonist
    warfarin
  20. Acts in the liver to prevent synthesis of vitamin K
    Action of warfarin
  21. Laboratory tests used to manage therapeutic range of warfarin
    PTT and INR
  22. Heparin is given prophylactically to patients to prevent these
    DVT and PE
  23. A potentially life-threatening complication of heparin administration leading to a decrease in platelet count and detectable HIT antibodies
    Heparin induced thrombocytopenia (HIT)
  24. laboratory test used to see if heparin is within therapeutic range
    aPTT